Cart summary

You have no items in your shopping cart.

    Sotuletinib dihydrochloride

    Sotuletinib dihydrochloride

    Catalog Number: orb1910560

    DispatchUsually dispatched within 5-10 working days
    Contact us for a quotation
    Catalog Numberorb1910560
    CategorySmall Molecules
    DescriptionSotuletinib, also known as BLZ945, is a potent and selective CSF-1R kinase inhibitor. BLZ945 showed effects of CSF1R inhibition on other tumor-infiltrating immune cells. BLZ945 attenuates the turnover rate of TAMs while increasing the number of CD8+ T cells that infiltrate cervical and breast carcinomas. BLZ945 decreases the growth of malignant cells in the mouse mammary tumor virus-driven polyomavirus middle T antigen (MMTV-PyMT) model of mammary carcinogenesis. BLZ945 prevents tumor progression in the keratin 14-expressing human papillomavirus type 16 (K14-HPV-16) transgenic model of cervical carcinogenesis.
    CAS Number[2222138-40-9]
    MW471.397
    SMILESO=C(NC)C1=NC=CC(OC2=CC=C3N=C(N[C@H]4[C@H](O)CCCC4)SC3=C2)=C1.[H]Cl.[H]Cl
    FormulaC20H24Cl2N4O3S
    NoteFor research use only
    Expiration Date12 months from date of receipt.
    • Sotuletinib dihydrochloride [orb1944510]

      98.00%

      2222138-40-9

      471.4

      C20H24Cl2N4O3S

      100 mg, 50 mg
    Submit a review

    Filter by Rating

      • Star
      • Star
      • Star
      • Star
      • Star
      • 5 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 4 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 3 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 2 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 1 stars